Anticonvulsants, ischemic seizures and regeneration in the immature brain

抗惊厥药、缺血性癫痫发作和未成熟大脑的再生

基本信息

  • 批准号:
    8492175
  • 负责人:
  • 金额:
    $ 33.1万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-08-01 至 2015-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Neonatal stroke affects one in 4000 term births and frequently results in cognitive impairments. Neonatal strokes present with seizures, and anticonvulsants (usually phenobarbital) are administered for months afterward. Our central hypothesis is that impaired hippocampal neurogenesis after neonatal stroke contributes to cognitive dysfunction, and anticonvulsants modulate both post-stroke neurogenesis and cognitive outcome. More specifically we hypothesize that anticonvulsants increasing GABA signaling decrease hippocampal neurogenesis and impair cognitive outcome, and anticonvulsants inhibiting histone deacetylase increase hippocampal neurogenesis and improve cognitive outcome. Approach: We will use a recently developed immature mouse model of ischemic seizures and brain injury. P12 CD1 mice will receive unilateral carotid ligation and BrdU labeling, and we will measure cognitive function, atrophy, and maturation of newborn hippocampal cells in the same animals. In a separate cohort of animals we will assess post-stroke integration of newborn neurons utilizing Arc-BrdU-NeuN co-labeling after a novel spatial task. We will determine the impact of chronically administered drugs that enhance GABA transmission or inhibit histone deacetylase upon atrophy, neurogenesis, cognitive impairment and chronic seizures in this model. Significance: Stroke in the immature brain causes cognitive impairment that often persists into adulthood. An intervention providing even partial reduction of cognitive impairment would result in significantly improved quality of life and decreased national healthcare costs. This work will determine which anticonvulsant is more likely to improve cognitive outcome after neonatal stroke and conversely which anticonvulsant should be avoided. This work will also reveal mechanistic insights regarding the role of GABA and histone deacetylase in neurogenesis and recovery after neonatal stroke. The background, training, and experience of the PI as a clinician scientist and pediatric neurologist make her uniquely suited and highly motivated to carry out this important research.
描述(由申请人提供):新生儿中风影响4000名足月新生儿中的一名,并经常导致认知障碍。新生儿中风表现为癫痫发作,随后数月给予抗惊厥药(通常为苯巴比妥)。我们的中心假设是新生儿卒中后海马神经发生受损导致认知功能障碍,抗惊厥药物调节卒中后神经发生和认知结果。更具体地说,我们假设抗惊厥药物增加GABA信号减少海马神经发生和损害认知结果,和抗惊厥药物抑制组蛋白脱乙酰酶增加海马神经发生和改善认知结果。方法:我们将使用最近开发的缺血性癫痫发作和脑损伤的未成熟小鼠模型。P12 CD 1小鼠将接受单侧颈动脉结扎和BrdU标记,我们将测量同一动物的认知功能、萎缩和新生海马细胞的成熟。在一个单独的动物队列中,我们将在一个新的空间任务后,利用Arc-BrdU-NeuN共标记评估中风后新生神经元的整合。我们将确定长期给药的药物,增强GABA的传输或抑制组蛋白去乙酰化酶后萎缩,神经发生,认知障碍和慢性癫痫发作在这个模型中的影响。意义:未成熟大脑中的中风导致认知障碍,通常持续到成年期。即使是部分减少认知障碍的干预措施也会显著改善生活质量,降低国家医疗保健成本。这项工作将确定哪种抗惊厥药物更有可能改善新生儿卒中后的认知结果,反之,应避免使用哪种抗惊厥药物。这项工作也将揭示有关GABA和组蛋白去乙酰化酶在新生儿中风后神经发生和恢复中的作用的机制见解。PI作为临床科学家和儿科神经科医生的背景,培训和经验使她非常适合并非常积极地开展这项重要的研究。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Corticospinal tract insult alters GABAergic circuitry in the mammalian spinal cord.
  • DOI:
    10.3389/fncir.2013.00150
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    3.5
  • 作者:
    Russ JB;Verina T;Comer JD;Comi AM;Kaltschmidt JA
  • 通讯作者:
    Kaltschmidt JA
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ANNE M COMI其他文献

ANNE M COMI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ANNE M COMI', 18)}}的其他基金

Brain MRI to pre-symptomatically predict seizure onset for Sturge-Weber Syndrome
脑部 MRI 可在症状前预测斯特奇-韦伯综合征的癫痫发作
  • 批准号:
    10680386
  • 财政年份:
    2022
  • 资助金额:
    $ 33.1万
  • 项目类别:
Anticonvulsants, ischemic seizures and regeneration in the immature brain
抗惊厥药、缺血性癫痫发作和未成熟大脑的再生
  • 批准号:
    7737038
  • 财政年份:
    2009
  • 资助金额:
    $ 33.1万
  • 项目类别:
Anticonvulsants, ischemic seizures and regeneration in the immature brain
抗惊厥药、缺血性癫痫发作和未成熟大脑的再生
  • 批准号:
    8289545
  • 财政年份:
    2009
  • 资助金额:
    $ 33.1万
  • 项目类别:
Anticonvulsants, ischemic seizures and regeneration in the immature brain
抗惊厥药、缺血性癫痫发作和未成熟大脑的再生
  • 批准号:
    8100418
  • 财政年份:
    2009
  • 资助金额:
    $ 33.1万
  • 项目类别:
Ischemic Injury and Neuroprotection in the Immature Brain
未成熟大脑的缺血性损伤和神经保护
  • 批准号:
    7433865
  • 财政年份:
    2006
  • 资助金额:
    $ 33.1万
  • 项目类别:
Ischemic Injury and Neuroprotection in the Immature Brain
未成熟大脑的缺血性损伤和神经保护
  • 批准号:
    7103130
  • 财政年份:
    2006
  • 资助金额:
    $ 33.1万
  • 项目类别:
Ischemic Injury and Neuroprotection in the Immature Brain
未成熟大脑的缺血性损伤和神经保护
  • 批准号:
    7608719
  • 财政年份:
    2006
  • 资助金额:
    $ 33.1万
  • 项目类别:
Ischemic Injury and Neuroprotection in the Immature Brain
未成熟大脑的缺血性损伤和神经保护
  • 批准号:
    7877734
  • 财政年份:
    2006
  • 资助金额:
    $ 33.1万
  • 项目类别:
Ischemic Injury and Neuroprotection in the Immature Brain
未成熟大脑的缺血性损伤和神经保护
  • 批准号:
    7229434
  • 财政年份:
    2006
  • 资助金额:
    $ 33.1万
  • 项目类别:
PATHOPHYSIOLOGY OF STURGE-WEBER
斯特奇-韦伯的病理生理学
  • 批准号:
    7604622
  • 财政年份:
    2006
  • 资助金额:
    $ 33.1万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 33.1万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.1万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 33.1万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.1万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 33.1万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 33.1万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.1万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 33.1万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 33.1万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.1万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了